Related references
Note: Only part of the references are listed.Minimal important difference estimates for patient-reported outcomes: A systematic survey
Alonso Carrasco-Labra et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
A conceptual map of health-related quality of life dimensions: key lessons for a new instrument
Jan Abel Olsen et al.
QUALITY OF LIFE RESEARCH (2020)
Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states
Gert Helgesson et al.
QUALITY OF LIFE RESEARCH (2020)
Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states
Marko Ogorevc et al.
HEALTH POLICY (2019)
Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study
Kristen Pickles et al.
SOCIAL SCIENCE & MEDICINE (2019)
Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare
Elizabeth F. Franklin et al.
VALUE IN HEALTH (2019)
Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores
Cheryl D. Coon et al.
QUALITY OF LIFE RESEARCH (2018)
Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes
Nathan S. McClure et al.
VALUE IN HEALTH (2018)
Quantifying life: Understanding the history of Quality-Adjusted Life-Years (QALYs)
Eleanor MacKillop et al.
SOCIAL SCIENCE & MEDICINE (2018)
Are preferences over health states informed?
M. Karimi et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Minimal important difference to infer changes in health-related quality of life-a systematic review
Ravishankar Jayadevappa et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models
John Brazier et al.
PHARMACOECONOMICS (2017)
Assessing treatment efficacy in the subset of responders in a randomized clinical trial
E. L. Korn et al.
ANNALS OF ONCOLOGY (2017)
Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care
Jeffrey A. Johnson et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)
A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada
Feng Xie et al.
MEDICAL CARE (2016)
Checklist to operationalize measurement characteristics of patient-reported outcome measures
David O. Francis et al.
SYSTEMATIC REVIEWS (2016)
An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis
Rachael Maree Hunter et al.
PHARMACOECONOMICS (2015)
Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care-Based Comparative Effectiveness Trial
Jeffrey A. Johnson et al.
DIABETES CARE (2014)
The use of research evidence on patient preferences in health care decision-making: issues, controversies and moving forward
Carmen D. Dirksen
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
Economics: the biggest fraud ever perpetrated on the world?
David Parkin et al.
LANCET (2013)
Controlled trial of a collaborative primary care team model for patients with diabetes and depression: Rationale and design for a comprehensive evaluation
Jeffrey A. Johnson et al.
BMC HEALTH SERVICES RESEARCH (2012)
The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research Implications for Clinical Practice and Health Care Policy
Sara Ahmed et al.
MEDICAL CARE (2012)
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study
Lidwine B. Mokkink et al.
QUALITY OF LIFE RESEARCH (2010)
Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies
Enrique F. Schisterman et al.
EPIDEMIOLOGY (2009)
The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects
Paul Kind et al.
VALUE IN HEALTH (2009)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility
A Manca et al.
HEALTH ECONOMICS (2005)
Measuring quality of life - Are quality of life measures patient centred?
AJ Carr et al.
BRITISH MEDICAL JOURNAL (2001)